Last reviewed · How we verify
PF-04802540
At a glance
| Generic name | PF-04802540 |
|---|---|
| Sponsor | Taisho Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia (PHASE1)
- A Study Of The Effect Of PF-04802540 On Sleep Measures (PHASE1)
- Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |